Structure

Physi-Chem Properties

Molecular Weight:  530.36
Volume:  558.158
LogP:  4.64
LogD:  3.835
LogS:  -4.314
# Rotatable Bonds:  5
TPSA:  85.22
# H-Bond Aceptor:  6
# H-Bond Donor:  2
# Rings:  6
# Heavy Atoms:  6

MedChem Properties

QED Drug-Likeness Score:  0.381
Synthetic Accessibility Score:  6.149
Fsp3:  0.906
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.19
MDCK Permeability:  1.2347240044618957e-05
Pgp-inhibitor:  0.897
Pgp-substrate:  0.996
Human Intestinal Absorption (HIA):  0.005
20% Bioavailability (F20%):  0.008
30% Bioavailability (F30%):  0.54

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.266
Plasma Protein Binding (PPB):  83.39327239990234%
Volume Distribution (VD):  1.726
Pgp-substrate:  10.836654663085938%

ADMET: Metabolism

CYP1A2-inhibitor:  0.007
CYP1A2-substrate:  0.925
CYP2C19-inhibitor:  0.013
CYP2C19-substrate:  0.883
CYP2C9-inhibitor:  0.049
CYP2C9-substrate:  0.027
CYP2D6-inhibitor:  0.005
CYP2D6-substrate:  0.215
CYP3A4-inhibitor:  0.961
CYP3A4-substrate:  0.71

ADMET: Excretion

Clearance (CL):  8.318
Half-life (T1/2):  0.085

ADMET: Toxicity

hERG Blockers:  0.294
Human Hepatotoxicity (H-HT):  0.581
Drug-inuced Liver Injury (DILI):  0.055
AMES Toxicity:  0.012
Rat Oral Acute Toxicity:  0.88
Maximum Recommended Daily Dose:  0.891
Skin Sensitization:  0.826
Carcinogencity:  0.843
Eye Corrosion:  0.01
Eye Irritation:  0.011
Respiratory Toxicity:  0.968

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC270586

Natural Product ID:  NPC270586
Common Name*:   QPYCAQVRIHEGFV-TXMWYVDOSA-N
IUPAC Name:   n.a.
Synonyms:  
Standard InCHIKey:  QPYCAQVRIHEGFV-TXMWYVDOSA-N
Standard InCHI:  InChI=1S/C32H50O6/c1-18(2)21-9-8-19(26(36-6)38-21)20-12-13-29(4)22-10-11-23-30(5,27(35)37-7)24(33)16-25(34)32(23)17-31(22,32)15-14-28(20,29)3/h19-26,33-34H,1,8-17H2,2-7H3/t19-,20-,21+,22+,23+,24+,25+,26+,28-,29+,30+,31+,32-/m1/s1
SMILES:  C=C(C)[C@@H]1CC[C@H]([C@H]2CC[C@@]3(C)[C@@H]4CC[C@H]5[C@@](C)([C@H](C[C@@H]([C@]65C[C@@]46CC[C@]23C)O)O)C(=O)OC)[C@@H](OC)O1
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL118708
PubChem CID:   44344630
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000258] Steroids and steroid derivatives
        • [CHEMONTID:0002321] Cycloartanols and derivatives

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO30384 Combretum quadrangulare Species Combretaceae Eukaryota n.a. n.a. n.a. PMID[10650080]
NPO30384 Combretum quadrangulare Species Combretaceae Eukaryota seeds n.a. n.a. PMID[10785422]
NPO30384 Combretum quadrangulare Species Combretaceae Eukaryota Seeds n.a. n.a. PMID[11277757]
NPO30384 Combretum quadrangulare Species Combretaceae Eukaryota n.a. leaf n.a. PMID[21265555]
NPO30384 Combretum quadrangulare Species Combretaceae Eukaryota leaves Khon Kaen, Thailand 2006-AUG PMID[21265555]
NPO30384 Combretum quadrangulare Species Combretaceae Eukaryota n.a. n.a. n.a. PMID[9934464]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. ED50 = 18.11 uM PMID[473791]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC270586 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.902 High Similarity NPC94906
0.8932 High Similarity NPC75941
0.8922 High Similarity NPC472028
0.8889 High Similarity NPC470311
0.8879 High Similarity NPC471250
0.8846 High Similarity NPC124544
0.8835 High Similarity NPC37047
0.8835 High Similarity NPC180733
0.8835 High Similarity NPC41971
0.8727 High Similarity NPC73986
0.8716 High Similarity NPC471251
0.8627 High Similarity NPC263135
0.8627 High Similarity NPC288906
0.8624 High Similarity NPC124053
0.8545 High Similarity NPC329953
0.8545 High Similarity NPC272242
0.8545 High Similarity NPC11035
0.8468 Intermediate Similarity NPC243572
0.8468 Intermediate Similarity NPC476964
0.8468 Intermediate Similarity NPC470543
0.8462 Intermediate Similarity NPC469810
0.844 Intermediate Similarity NPC88744
0.8426 Intermediate Similarity NPC295366
0.8426 Intermediate Similarity NPC285927
0.8426 Intermediate Similarity NPC4115
0.8426 Intermediate Similarity NPC12823
0.8421 Intermediate Similarity NPC239293
0.8411 Intermediate Similarity NPC139347
0.8407 Intermediate Similarity NPC469820
0.8407 Intermediate Similarity NPC469823
0.8393 Intermediate Similarity NPC102619
0.8393 Intermediate Similarity NPC146563
0.8365 Intermediate Similarity NPC234564
0.8364 Intermediate Similarity NPC469983
0.8364 Intermediate Similarity NPC473844
0.8364 Intermediate Similarity NPC476759
0.8364 Intermediate Similarity NPC91583
0.8364 Intermediate Similarity NPC240125
0.8364 Intermediate Similarity NPC51947
0.8349 Intermediate Similarity NPC61071
0.8349 Intermediate Similarity NPC263729
0.8319 Intermediate Similarity NPC471357
0.8319 Intermediate Similarity NPC117702
0.8319 Intermediate Similarity NPC54395
0.8319 Intermediate Similarity NPC146456
0.8319 Intermediate Similarity NPC469757
0.8318 Intermediate Similarity NPC170615
0.8318 Intermediate Similarity NPC94919
0.8288 Intermediate Similarity NPC98633
0.8288 Intermediate Similarity NPC130302
0.8288 Intermediate Similarity NPC255655
0.8273 Intermediate Similarity NPC232133
0.8273 Intermediate Similarity NPC230888
0.8273 Intermediate Similarity NPC469733
0.8273 Intermediate Similarity NPC469729
0.8273 Intermediate Similarity NPC224414
0.8261 Intermediate Similarity NPC469822
0.8257 Intermediate Similarity NPC165405
0.8252 Intermediate Similarity NPC473690
0.8252 Intermediate Similarity NPC471902
0.8252 Intermediate Similarity NPC287118
0.8246 Intermediate Similarity NPC137414
0.823 Intermediate Similarity NPC285086
0.8224 Intermediate Similarity NPC71706
0.8224 Intermediate Similarity NPC46848
0.8214 Intermediate Similarity NPC204392
0.8214 Intermediate Similarity NPC91838
0.8214 Intermediate Similarity NPC240734
0.8214 Intermediate Similarity NPC1876
0.8214 Intermediate Similarity NPC275668
0.8208 Intermediate Similarity NPC474793
0.8205 Intermediate Similarity NPC470478
0.8198 Intermediate Similarity NPC469744
0.819 Intermediate Similarity NPC329910
0.819 Intermediate Similarity NPC317573
0.8182 Intermediate Similarity NPC469754
0.8182 Intermediate Similarity NPC469751
0.8182 Intermediate Similarity NPC284406
0.8182 Intermediate Similarity NPC469755
0.8182 Intermediate Similarity NPC469753
0.8182 Intermediate Similarity NPC180079
0.8182 Intermediate Similarity NPC89514
0.8182 Intermediate Similarity NPC469752
0.8182 Intermediate Similarity NPC471358
0.8182 Intermediate Similarity NPC10823
0.8182 Intermediate Similarity NPC470952
0.8182 Intermediate Similarity NPC471360
0.8182 Intermediate Similarity NPC88833
0.8182 Intermediate Similarity NPC70542
0.8182 Intermediate Similarity NPC86159
0.8182 Intermediate Similarity NPC471359
0.8182 Intermediate Similarity NPC219085
0.8182 Intermediate Similarity NPC9499
0.8182 Intermediate Similarity NPC251866
0.8182 Intermediate Similarity NPC471352
0.8182 Intermediate Similarity NPC17896
0.8182 Intermediate Similarity NPC6108
0.8182 Intermediate Similarity NPC471361
0.8182 Intermediate Similarity NPC197707
0.8182 Intermediate Similarity NPC96333
0.8174 Intermediate Similarity NPC473304
0.8174 Intermediate Similarity NPC156651
0.8165 Intermediate Similarity NPC101842
0.8165 Intermediate Similarity NPC202793
0.8158 Intermediate Similarity NPC469821
0.8155 Intermediate Similarity NPC475416
0.8155 Intermediate Similarity NPC471901
0.8148 Intermediate Similarity NPC309388
0.8148 Intermediate Similarity NPC475803
0.8148 Intermediate Similarity NPC286519
0.8148 Intermediate Similarity NPC214946
0.8148 Intermediate Similarity NPC193934
0.8148 Intermediate Similarity NPC275990
0.8148 Intermediate Similarity NPC271980
0.8148 Intermediate Similarity NPC88203
0.8148 Intermediate Similarity NPC76866
0.8148 Intermediate Similarity NPC304832
0.8148 Intermediate Similarity NPC148628
0.8148 Intermediate Similarity NPC246736
0.8142 Intermediate Similarity NPC471245
0.813 Intermediate Similarity NPC32793
0.813 Intermediate Similarity NPC247190
0.813 Intermediate Similarity NPC116075
0.813 Intermediate Similarity NPC146857
0.813 Intermediate Similarity NPC469749
0.8125 Intermediate Similarity NPC49730
0.8125 Intermediate Similarity NPC98069
0.8125 Intermediate Similarity NPC106760
0.8125 Intermediate Similarity NPC476766
0.812 Intermediate Similarity NPC470312
0.8113 Intermediate Similarity NPC253586
0.8108 Intermediate Similarity NPC476765
0.8108 Intermediate Similarity NPC63841
0.8108 Intermediate Similarity NPC163216
0.8095 Intermediate Similarity NPC266431
0.8095 Intermediate Similarity NPC470229
0.8095 Intermediate Similarity NPC470232
0.8091 Intermediate Similarity NPC28791
0.8091 Intermediate Similarity NPC103172
0.8091 Intermediate Similarity NPC37600
0.8091 Intermediate Similarity NPC164600
0.8087 Intermediate Similarity NPC88945
0.8077 Intermediate Similarity NPC475061
0.8073 Intermediate Similarity NPC470310
0.8073 Intermediate Similarity NPC312900
0.8067 Intermediate Similarity NPC27363
0.8065 Intermediate Similarity NPC329636
0.8056 Intermediate Similarity NPC471790
0.8056 Intermediate Similarity NPC163963
0.8056 Intermediate Similarity NPC14634
0.8056 Intermediate Similarity NPC236585
0.8056 Intermediate Similarity NPC289148
0.8056 Intermediate Similarity NPC253886
0.8056 Intermediate Similarity NPC52899
0.8056 Intermediate Similarity NPC121218
0.8053 Intermediate Similarity NPC250481
0.8053 Intermediate Similarity NPC122339
0.8053 Intermediate Similarity NPC94650
0.8053 Intermediate Similarity NPC285410
0.8053 Intermediate Similarity NPC263827
0.8039 Intermediate Similarity NPC146937
0.8037 Intermediate Similarity NPC20479
0.8037 Intermediate Similarity NPC38296
0.8037 Intermediate Similarity NPC28864
0.8037 Intermediate Similarity NPC119036
0.8037 Intermediate Similarity NPC162459
0.8037 Intermediate Similarity NPC471038
0.8037 Intermediate Similarity NPC38471
0.8037 Intermediate Similarity NPC98837
0.8036 Intermediate Similarity NPC8431
0.8036 Intermediate Similarity NPC257082
0.8036 Intermediate Similarity NPC285298
0.8019 Intermediate Similarity NPC327788
0.8018 Intermediate Similarity NPC86852
0.8018 Intermediate Similarity NPC469746
0.8018 Intermediate Similarity NPC186054
0.8018 Intermediate Similarity NPC251824
0.8018 Intermediate Similarity NPC287269
0.8017 Intermediate Similarity NPC329784
0.8017 Intermediate Similarity NPC240070
0.8017 Intermediate Similarity NPC42399
0.8017 Intermediate Similarity NPC179412
0.8017 Intermediate Similarity NPC298841
0.8017 Intermediate Similarity NPC471356
0.8 Intermediate Similarity NPC194716
0.8 Intermediate Similarity NPC476763
0.8 Intermediate Similarity NPC476764
0.8 Intermediate Similarity NPC116024
0.8 Intermediate Similarity NPC470385
0.8 Intermediate Similarity NPC470386
0.8 Intermediate Similarity NPC47853
0.8 Intermediate Similarity NPC469982
0.8 Intermediate Similarity NPC475118
0.8 Intermediate Similarity NPC201763
0.8 Intermediate Similarity NPC472274
0.8 Intermediate Similarity NPC318135
0.7982 Intermediate Similarity NPC473303
0.7982 Intermediate Similarity NPC40608
0.7982 Intermediate Similarity NPC471244
0.7967 Intermediate Similarity NPC173347

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC270586 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.823 Intermediate Similarity NPD8133 Approved
0.8182 Intermediate Similarity NPD7319 Approved
0.7934 Intermediate Similarity NPD7507 Approved
0.7661 Intermediate Similarity NPD7736 Approved
0.7642 Intermediate Similarity NPD8034 Phase 2
0.7642 Intermediate Similarity NPD8035 Phase 2
0.7573 Intermediate Similarity NPD7520 Clinical (unspecified phase)
0.7563 Intermediate Similarity NPD8295 Clinical (unspecified phase)
0.7545 Intermediate Similarity NPD7638 Approved
0.75 Intermediate Similarity NPD7328 Approved
0.75 Intermediate Similarity NPD7327 Approved
0.748 Intermediate Similarity NPD8328 Phase 3
0.7478 Intermediate Similarity NPD5345 Clinical (unspecified phase)
0.7477 Intermediate Similarity NPD7639 Approved
0.7477 Intermediate Similarity NPD7640 Approved
0.7459 Intermediate Similarity NPD8378 Approved
0.7459 Intermediate Similarity NPD8335 Approved
0.7459 Intermediate Similarity NPD8296 Approved
0.7459 Intermediate Similarity NPD8380 Approved
0.7459 Intermediate Similarity NPD8379 Approved
0.744 Intermediate Similarity NPD8293 Discontinued
0.7438 Intermediate Similarity NPD7516 Approved
0.7377 Intermediate Similarity NPD8294 Approved
0.7377 Intermediate Similarity NPD8377 Approved
0.7328 Intermediate Similarity NPD6686 Approved
0.7317 Intermediate Similarity NPD8033 Approved
0.7265 Intermediate Similarity NPD8132 Clinical (unspecified phase)
0.7258 Intermediate Similarity NPD6370 Approved
0.7241 Intermediate Similarity NPD6412 Phase 2
0.7217 Intermediate Similarity NPD8170 Clinical (unspecified phase)
0.7143 Intermediate Similarity NPD7492 Approved
0.7131 Intermediate Similarity NPD7115 Discovery
0.7097 Intermediate Similarity NPD6054 Approved
0.7097 Intermediate Similarity NPD6059 Approved
0.7087 Intermediate Similarity NPD6616 Approved
0.7083 Intermediate Similarity NPD6882 Approved
0.7059 Intermediate Similarity NPD6697 Approved
0.7059 Intermediate Similarity NPD6114 Approved
0.7059 Intermediate Similarity NPD6118 Approved
0.7059 Intermediate Similarity NPD6115 Approved
0.7043 Intermediate Similarity NPD7632 Discontinued
0.704 Intermediate Similarity NPD8515 Approved
0.704 Intermediate Similarity NPD8517 Approved
0.704 Intermediate Similarity NPD8513 Phase 3
0.704 Intermediate Similarity NPD8516 Approved
0.7031 Intermediate Similarity NPD7078 Approved
0.7009 Intermediate Similarity NPD5739 Approved
0.7009 Intermediate Similarity NPD6402 Approved
0.7009 Intermediate Similarity NPD6675 Approved
0.7009 Intermediate Similarity NPD7128 Approved
0.6905 Remote Similarity NPD7503 Approved
0.6905 Remote Similarity NPD6015 Approved
0.6905 Remote Similarity NPD6016 Approved
0.6891 Remote Similarity NPD6881 Approved
0.6891 Remote Similarity NPD7320 Approved
0.6891 Remote Similarity NPD6899 Approved
0.6875 Remote Similarity NPD7748 Approved
0.6863 Remote Similarity NPD6117 Approved
0.686 Remote Similarity NPD8130 Phase 1
0.6855 Remote Similarity NPD6009 Approved
0.685 Remote Similarity NPD5988 Approved
0.6833 Remote Similarity NPD6373 Approved
0.6833 Remote Similarity NPD4061 Clinical (unspecified phase)
0.6833 Remote Similarity NPD6372 Approved
0.6825 Remote Similarity NPD6319 Approved
0.6818 Remote Similarity NPD5328 Approved
0.6807 Remote Similarity NPD5697 Approved
0.6807 Remote Similarity NPD5701 Approved
0.6803 Remote Similarity NPD8297 Approved
0.6796 Remote Similarity NPD6116 Phase 1
0.6786 Remote Similarity NPD6399 Phase 3
0.6777 Remote Similarity NPD7290 Approved
0.6777 Remote Similarity NPD6883 Approved
0.6777 Remote Similarity NPD7102 Approved
0.6772 Remote Similarity NPD6921 Approved
0.6723 Remote Similarity NPD6008 Approved
0.6721 Remote Similarity NPD6847 Approved
0.6721 Remote Similarity NPD6617 Approved
0.6721 Remote Similarity NPD6869 Approved
0.6721 Remote Similarity NPD6649 Approved
0.6721 Remote Similarity NPD6650 Approved
0.6696 Remote Similarity NPD6411 Approved
0.6696 Remote Similarity NPD7637 Suspended
0.6696 Remote Similarity NPD7902 Approved
0.6696 Remote Similarity NPD7515 Phase 2
0.6696 Remote Similarity NPD6079 Approved
0.6694 Remote Similarity NPD6014 Approved
0.6694 Remote Similarity NPD6013 Approved
0.6694 Remote Similarity NPD6012 Approved
0.6667 Remote Similarity NPD7604 Phase 2
0.6667 Remote Similarity NPD6113 Clinical (unspecified phase)
0.6639 Remote Similarity NPD5955 Clinical (unspecified phase)
0.6613 Remote Similarity NPD4632 Approved
0.6612 Remote Similarity NPD6011 Approved
0.6602 Remote Similarity NPD3703 Phase 2
0.6591 Remote Similarity NPD6033 Approved
0.6585 Remote Similarity NPD6401 Clinical (unspecified phase)
0.6552 Remote Similarity NPD6084 Phase 2
0.6552 Remote Similarity NPD4755 Approved
0.6552 Remote Similarity NPD6083 Phase 2
0.6532 Remote Similarity NPD6053 Discontinued
0.6518 Remote Similarity NPD6101 Approved
0.6518 Remote Similarity NPD5764 Clinical (unspecified phase)
0.6514 Remote Similarity NPD4786 Approved
0.6508 Remote Similarity NPD6940 Discontinued
0.6504 Remote Similarity NPD4634 Approved
0.6496 Remote Similarity NPD4225 Approved
0.6491 Remote Similarity NPD8171 Discontinued
0.6491 Remote Similarity NPD5778 Approved
0.6491 Remote Similarity NPD5779 Approved
0.6471 Remote Similarity NPD5211 Phase 2
0.6466 Remote Similarity NPD5221 Approved
0.6466 Remote Similarity NPD5222 Approved
0.6466 Remote Similarity NPD5220 Clinical (unspecified phase)
0.6466 Remote Similarity NPD4697 Phase 3
0.6449 Remote Similarity NPD6928 Phase 2
0.6441 Remote Similarity NPD4700 Approved
0.6441 Remote Similarity NPD4696 Approved
0.6441 Remote Similarity NPD5286 Approved
0.6441 Remote Similarity NPD5285 Approved
0.6435 Remote Similarity NPD7901 Clinical (unspecified phase)
0.6435 Remote Similarity NPD7900 Approved
0.6429 Remote Similarity NPD7513 Clinical (unspecified phase)
0.6422 Remote Similarity NPD4788 Approved
0.6412 Remote Similarity NPD6067 Discontinued
0.641 Remote Similarity NPD5173 Approved
0.6396 Remote Similarity NPD3618 Phase 1
0.6393 Remote Similarity NPD5954 Clinical (unspecified phase)
0.6391 Remote Similarity NPD8074 Phase 3
0.6385 Remote Similarity NPD5983 Phase 2
0.6379 Remote Similarity NPD6356 Clinical (unspecified phase)
0.6378 Remote Similarity NPD6868 Approved
0.6378 Remote Similarity NPD6274 Approved
0.6364 Remote Similarity NPD5141 Approved
0.6357 Remote Similarity NPD7101 Approved
0.6357 Remote Similarity NPD7100 Approved
0.6333 Remote Similarity NPD5224 Approved
0.6333 Remote Similarity NPD5226 Approved
0.6333 Remote Similarity NPD4633 Approved
0.6333 Remote Similarity NPD5225 Approved
0.633 Remote Similarity NPD3667 Approved
0.6316 Remote Similarity NPD6336 Discontinued
0.6311 Remote Similarity NPD4808 Clinical (unspecified phase)
0.6311 Remote Similarity NPD4809 Clinical (unspecified phase)
0.6296 Remote Similarity NPD7525 Registered
0.6286 Remote Similarity NPD3702 Approved
0.6283 Remote Similarity NPD6672 Approved
0.6283 Remote Similarity NPD5737 Approved
0.6281 Remote Similarity NPD5174 Approved
0.6281 Remote Similarity NPD5175 Approved
0.6279 Remote Similarity NPD6335 Approved
0.626 Remote Similarity NPD6908 Approved
0.626 Remote Similarity NPD6909 Approved
0.625 Remote Similarity NPD1700 Approved
0.625 Remote Similarity NPD6684 Approved
0.625 Remote Similarity NPD6409 Approved
0.625 Remote Similarity NPD5330 Approved
0.625 Remote Similarity NPD7521 Approved
0.625 Remote Similarity NPD7334 Approved
0.625 Remote Similarity NPD7146 Approved
0.625 Remote Similarity NPD5223 Approved
0.6239 Remote Similarity NPD5695 Phase 3
0.6218 Remote Similarity NPD5696 Approved
0.6207 Remote Similarity NPD4202 Approved
0.6202 Remote Similarity NPD6317 Approved
0.6195 Remote Similarity NPD3573 Approved
0.619 Remote Similarity NPD8413 Clinical (unspecified phase)
0.6186 Remote Similarity NPD7839 Suspended
0.6179 Remote Similarity NPD4768 Approved
0.6179 Remote Similarity NPD4767 Approved
0.6154 Remote Similarity NPD6314 Approved
0.6154 Remote Similarity NPD6313 Approved
0.6148 Remote Similarity NPD4754 Approved
0.614 Remote Similarity NPD6903 Approved
0.6126 Remote Similarity NPD6695 Phase 3
0.6121 Remote Similarity NPD5693 Phase 1
0.6117 Remote Similarity NPD3699 Clinical (unspecified phase)
0.6117 Remote Similarity NPD3700 Clinical (unspecified phase)
0.6111 Remote Similarity NPD6371 Approved
0.6087 Remote Similarity NPD6051 Approved
0.6087 Remote Similarity NPD7799 Discontinued
0.6087 Remote Similarity NPD4753 Phase 2
0.608 Remote Similarity NPD4729 Approved
0.608 Remote Similarity NPD5128 Approved
0.608 Remote Similarity NPD4730 Approved
0.6071 Remote Similarity NPD3133 Approved
0.6071 Remote Similarity NPD7338 Clinical (unspecified phase)
0.6071 Remote Similarity NPD3665 Phase 1
0.6071 Remote Similarity NPD3666 Approved
0.6055 Remote Similarity NPD7645 Phase 2
0.6053 Remote Similarity NPD7750 Discontinued
0.6043 Remote Similarity NPD8338 Approved
0.6036 Remote Similarity NPD4752 Clinical (unspecified phase)
0.6034 Remote Similarity NPD46 Approved
0.6034 Remote Similarity NPD6698 Approved
0.6033 Remote Similarity NPD8418 Phase 2
0.6017 Remote Similarity NPD6001 Approved
0.6015 Remote Similarity NPD6291 Clinical (unspecified phase)
0.6014 Remote Similarity NPD6914 Discontinued
0.6 Remote Similarity NPD5777 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data